Clinical trial

A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy

NCT07831863

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-10-01

PhasePHASE3

Study timeline

Study start (estimated)2026-10-01Date precision: month

Registry last updated2026-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Squamous Cell Carcinomaunresolved

Interventions

7MW3711DRUG

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Mabwell (Shanghai) Bioscience Co., Ltd.lead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07831863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.